Request Discount

Stool Secretory Immunoglobulin a [SIgA] Market (Types - Allergic Disease, Infection, GI Inflammation, and Autoimmune Disease; Applications - Hospitals, Labs and Diagnostic Centers, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

  • Published : July, 2021

  • Rep Id : HC08699

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on stool secretory immunoglobulin a [SIgA] market provides in-depth analysis of segments and sub-segments in the global as well as regional stool secretory immunoglobulin a [SIgA] market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional stool secretory immunoglobulin a [SIgA] market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of global stool secretory immunoglobulin a [SIgA] market. According to the report, the global stool secretory immunoglobulin a [SIgA] market is projected to grow at a healthy CAGR over the forecast period of 2021-2027.


Market Insight

The secretion of the immunoglobulin a (IgA) antibody is one of the primary defense mechanisms protecting against enteric infections in both human and animal models. It further provides protective effects by binding to microbial antigens, toxins, and food proteins. The coronavirus disease (COVID-19) causes all the healthcare R&D activities to remain steady. Research and development activities are likely to continue in, as governments in all the nations have given a large preference to research and development activities pertaining to the healthcare sector. As the primary focus of governments around the globe is on curbing the transmission of the novel COVID-19 infection. Hence the growth of the stool secretory immunoglobulin a (SIgA) market is anticipated to remain steady during the COVID-19 pandemic.


Secretory immunoglobulin a (SIgA) is the dominant immunoglobulin in external secretions that bathe mucosal surfaces and is a vital component of the immune system against pathogenic microorganisms, viruses, and bacteria. SIgA production is both beneficially and adversely affected by a number of diverse factors including stress, emotions such as frustration and anger, nutrients, commensals, pathogens, and inflammation. A reduced mucosal barrier function may increase the risk for allergy development and immunoglobulin A (IgA) is the primary mediator of humoral mucosal immunity. Immunoglobulin A is the most abundantly produced antibody in humans, with the highest amount of secretion in the intestinal tract Secretory IgA (SIgA), has a crucial role in the gut through its binding to bacterial antigens, thus preventing their direct interaction with the host via immune exclusion and maintaining the mucosal homeostasis. Growing adoption of diagnosis of selective IgA deficiency in suspected cases due to chronic or recurrent infections, autoimmune diseases, chronic diarrhea, and benefits offered by secretory immunoglobulin A (SIgA) diagnostics are expected to boosts the market growth. Furthermore, a notable rise in the adoption of preventive care for a healthier lifestyle is fuelling the market growth of stool secretory immunoglobulin a (SIgA) during the assessment period. However, imposing pricing pressure on major manufacturers is intensifying competition in the market. A local player offering a wide range of reagents portfolios at lower rates is hampering the geographic expansion of major players. Moreover, advancements in stool secretory immunoglobulin a (SIgA) continue to highlight the interaction between the host and microbiome which, provides a significant growth opportunity for the market.


North America dominates the secretory immunoglobulin a (SIgA) market. An increase in recurrent respiratory tract infections, gastric infections, and the growing occurrence of autoimmune diseases in North America is projected to provide a growing demand for the secretory immunoglobulin a (SIgA) diagnostics market. A large stool secretory immunoglobulin tests are performed by standalone and hospital-based diagnostic laboratories in the U.S. Furthermore, the presence of major standalone laboratories, such as Laboratory Corporation of America Holdings (LabCorp) testing a higher volume of the patient population in the U.S. and Germany. The higher rate of adoption of new tests and instruments by diagnostic laboratories for secretory immunoglobulin diagnosis are key factors likely to drive the demand for stool secretory immunoglobulin A in the labs and diagnostic centers segment. The use of probiotics is increasing rapidly despite questionable evidence of efficacy, particularly as it relates to pediatric acute gastroenteritis (AGE). However, the interest in probiotics is founded on how they may contribute to immune homeostasis by altering the microbial balance, interacting with the host immune system, regulating inflammatory cytokines, and increasing SIgA production.


Stool Secretory Immunoglobulin a [SIgA] Market

Segment Covered

The report on global stool secretory immunoglobulin a [SIgA] market covers segments such as types, and applications. On the basis of types, the sub-markets include allergic disease, infection, GI inflammation, and autoimmune disease. On the basis of applications, the sub-markets include hospitals, labs and diagnostic centers, and others.


Companies Profiled:

The report provides profiles of the companies in the market such as BioVendor Group, Sigma Diagnostics Inc, Calbiotech, Inc, Eagle Biosciences, American Laboratory Products Company, R-Biopharm AG, Tecan Trading AG, and Others.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of stool secretory immunoglobulin a [SIgA] market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount